Control BionicsASX:CBL -5.13% Days Inventory is 50.25 as of Dec. 2025, which is 54% below its 10-year median of 110.07. The stock has 6 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Control Bionics ranks better than 90.59% on this metric.
The historical rank and industry rank for Control Bionics's Days Inventory or its related term are showing as below:
ASX:CBL'
s Days Inventory Range Over the Past 10 Years
Min: 57.17 Med: 110.07 Max: 163.13
Current: 69.07
During the past 6 years, Control Bionics's highest Days Inventory was 163.13. The lowest was 57.17. And the median was 110.07.
ASX:CBL's Days Inventory is ranked better than 90.59% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs ASX:CBL: 69.07
Control Bionics's Days Inventory
declined
from Dec. 2024 (83.87) to Dec. 2025 (50.25).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Control Bionics's Inventory Turnover for the
six
months ended in Dec. 2025 was 3.63.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Control Bionics's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.14.
Control Bionics (ASX:CBL) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Control Bionics's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Control Bionics's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Control Bionics Days Inventory Related Terms
Control Bionics Days Inventory Historical Data
* Premium members only.
The historical data trend for Control Bionics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:CBL vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, Control Bionics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Control Bionics Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Control Bionics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Control Bionics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Control Bionics (ASX:CBL) has a Days Inventory of 50.25 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Control Bionics and its competitors. This is 54% below median its historical median of 110.07. Over the past decade, Control Bionics' Days Inventory has ranged from 57.17 to 163.13. According to the industry distribution chart, Control Bionics ranks #74 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 9.4%.
Is Control Bionics' Days Inventory too high?
Control Bionics' current Days Inventory of 50.25 is 54% below median its 10-year median of 110.07. Over the past 10 years, this metric has ranged from a low of 57.17 to a high of 163.13. The Medical Devices & Instruments industry median Days Inventory is 179.60. Control Bionics' value of 50.25 is 72% below this industry median. Based on the distribution chart, Control Bionics ranks #74 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Control Bionics' Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Control Bionics ranks #74 out of 786 companies for Days Inventory. This places Control Bionics in the top 9% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. Control Bionics' value of 50.25 is 72% below this benchmark. Historically, Control Bionics' own Days Inventory has ranged from 57.17 to 163.13 over the past decade. While the company's 10-year median is 110.07 vs. the industry median of 179.60, Control Bionics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Control Bionics's current Days Inventory of 50.25 is 72% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Control Bionics and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Control Bionics's current Days Inventory is 50.25, which is 54% below median its own 10-year median of 110.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.07 — trading 146.7% above its estimated fair value. The current Days Inventory is 50.25, which is 54% below median its 10-year median of 110.07 and 72% below the Medical Devices & Instruments industry median of 179.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current Days Inventory is 50.25 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CBL has been successfully added to your 